Samsung Surpasses Apple with Sleep Apnea Detection in FDA-Approved Galaxy Watch
Samsung Electronics has achieved a significant milestone in the health technology sector by obtaining de novo authorization from the Food and Drug Administration (FDA)...
Uniting for Maternal Health: The HHS Secretary’s Initiative to Tackle Postpartum Mortality Nationwide
Health and Human Services (HHS) Secretary Xavier Becerra, along with HHS leaders, recently convened with state officials and the National Governors Association (NGA) to...
Medicare Prescription Payment Plan: A New Era of Financial Relief for Part D Enrollees
The Centers for Medicare & Medicaid Services (CMS) has recently issued further guidance on the Medicare Prescription Payment Plan, a key component of the...
HHS Announces Final Phase Winners in Postpartum Care Challenge to Address Racial Equity
The U.S. Department of Health and Human Services (HHS), through the Office on Women’s Health (OWH) and the Centers for Medicare & Medicaid Services...
Partnership to Revolutionize Digital Pathology and Precision Medicine with AI by Roche and PathAI
Roche has unveiled a landmark partnership with PathAI to enhance digital pathology with artificial intelligence (AI), targeting companion diagnostics. This collaboration is set to...
European Commission Approves Beta Thalassemia Treatment CASGEVY
Vertex Pharmaceuticals Incorporated has reached a significant achievement in the realm of severe sickle cell disease and beta thalassemia treatment with the European Commission...
Soft Robotic Exosuit for Parkinson’s Patients, Provides Hope and Improved Mobility
Researchers at the Harvard John A Paulson School of Engineering and Applied Sciences (SEAS) in the United States, in conjunction with the Boston University...
Bristol Myers’ $14 Billion Gamble: Acquiring Karuna for Groundbreaking Schizophrenia Treatment
Bristol Myers Squibb is making waves in the pharmaceutical world with its $14 billion acquisition of Karuna Therapeutics, signifying confidence in Karuna's experimental schizophrenia...
Stakeholder Collaboration for the European Health Data Space (EHDS) Regulation
A collective of prominent stakeholder organizations, representing patients, healthcare professionals, researchers, and industry players within the European Union (EU) and its Member States, is...
Overhauling Europe’s Pharmaceutical Framework: A Critical Assessment of the General Pharmaceutical Legislation Revision
In a historic move, Europe is overhauling its pharmaceutical framework for the first time in two decades. The revision of the General Pharmaceutical Legislation...
FDA Approves Eflornithine for High-Risk Neuroblastoma Relapse Prevention in Pediatric Patients
The FDA has approved eflornithine (Iwilfin), marking a significant milestone in treating high-risk neuroblastoma (HRNB). This groundbreaking decision paves the way for enhanced relapse...
ZURZUVAE The New Breakthrough for Postpartum Depression Treatment
In a groundbreaking development, Biogen Inc. and Sage Therapeutics, Inc. have jointly announced the availability of ZURZUVAE™ (zuranolone) 50 mg as an oral treatment...
Health Monitoring Device for Women: Portable to Track Hormones and Symptoms
In a remarkable development, scientists are actively working on a portable health monitoring device that empowers women to track and monitor their health and...
ASH23 Highlights: CAR-T Potential for Autoimmune Disease and Sickle Cell Disease Treatment
The 65th annual meeting of the American Society of Hematology (ASH) began with a significant development as the FDA approved two gene therapies for...
HIQA Initiates Assessment for Shingles Vaccine Inclusion in Irish Adult Immunization Schedule
The Health Information and Quality Authority (HIQA) has taken the first step towards potentially adding the shingles vaccine to the adult immunization schedule in...
